Skip to main content
Fig. 2 | Journal of Biological Engineering

Fig. 2

From: Chitosan modified with PAP as a promising delivery system for melatonin in the treatment of osteoporosis: targeting the divalent metal transporter 1

Fig. 2

The effect of melatonin (MT) on cell viability and gene expression. (A). Three day CCK-8 cell viabilities determined after treatments with different concentrations of MT. (B). RT-PCR of samples treated with different concentrations of MT. n = 6 for each group. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001

Back to article page

Journal of Biological Engineering

ISSN: 1754-1611